Nephrocare Health Services Ltd

NSE: NEPHROPLUS · BSE: 544647 · Healthcare · 44 announcements

Share price: ₹643.00
Market cap: ₹6,452 Cr
Revenue (annual): ₹998.8 Cr
Net profit (annual): ₹76.84 Cr
P/E (TTM): 75.8×Sector 53.1×
Promoter holding: 63.85%+0.00% QoQ
FII holding: 8.78%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 11 Acquisition 6 Earnings Call 4 Financial Results 3 Employee Stock Options 3 Board Meeting Date 3 Results Update 2 Other Announcement 2 Management Change 2 Debt & Borrowing 2 Annual General Meeting 2 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

19 May 2026 19:40 IST NSE

Management Change

Nephrocare Health Services Management Change

Nephrocare Health Services appointed BDO India LLP as Internal Auditor for a twelve-month term. The move aims to strengthen internal controls and risk management practices.

Execution: 12 months

Read the filing ↗

3 Apr 2026 12:05 IST NSE

Management Change

Nephrocare Health Services Management Change

Nephrocare Health Services Limited has designated its CFO, Mr. Prashant Vinodkumar Goenka, as the Chief Risk Officer with effect from April 03, 2026. Mr. Goenka brings over 20 years of experience from global financial institutions like HSBC and JP Morgan. This additional responsibility aims to strengthen the company's risk management framework.

Read the filing ↗